Pulse Biosciences Inc

NASDAQ:PLSE   3:59:53 PM EDT
1.99
-0.15 (-7.01%)
Layoffs, Restructuring / Reorganization, Earnings Announcements

Pulse Biosciences Says On March 31, 2022, Company Initiated A Plan To Reduce Its Operating Expenses, Preserve Financial Resources

Published: 03/31/2022 21:29 GMT
Pulse Biosciences Inc (PLSE) - Pulse Biosciences Inc - on March 31, 2022, Company Initiated a Plan to Reduce Its Operating Expenses, Preserve Financial Resources.
Pulse Biosciences - Initiated Plan to Focus Its Sales and Marketing Efforts on Increasing Utilization of Commercial Cellfx Systems.
Pulse Biosciences Inc - the Actions Are Expected to Result in Reduction of Total Operating Expenses in 2022 of About 20% From Current Run Rate.
Pulse Biosciences Inc - Expects a Reduction in Its Current Workforce by About 15 to 20%, to Be Completed Within a Few Weeks.
Pulse Biosciences Inc - Restructuring Actions Associated With the Charges Are Expected to Be Complete in 2022.
Pulse Biosciences Inc - Has Initiated Operating Expense Reduction Programs Across Company.
Pulse Biosciences - Board Approved Changes to Commercial Leadership, Restructuring of Commercial Field Organization and Reductions in Other Expenses.
Further Company Coverage: Plseo ((reuters.
Briefs@thomsonreuters.
Com;)).
Revenue is expected to be $0.44 Million
Adjusted EPS is expected to be -$0.40

Next Quarter Revenue Guidance is expected to be $0.46 Million
Next Quarter EPS Guidance is expected to be -$0.37

More details on our Analysts Page.